Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Pharmacy Focus: Oncology Edition : Episode 2
Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer
Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.
In the second episode of Pharmacy Focus: Oncology Edition, Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.
EP: 1.Pharmacy Focus: Oncology Edition - A Conversation About Biden's Cancer Moonshot Program
Now Viewing
EP: 2.Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer
EP: 3.Pharmacy Focus: Oncology Edition - What You Missed at ASCO 2022
EP: 4.Pharmacy Focus: Oncology Edition - A Look Ahead at the Pipeline for Melanoma
EP: 5.Pharmacy Focus: Oncology Edition - An Update on Prostate Cancer and the Growing Role of Pharmacists
EP: 6.Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
EP: 7.Pharmacy Focus: Oncology Edition - Pharmacists Play Key Role in Non–Small Cell Lung Cancer
EP: 8.Pharmacy Focus: Oncology Edition - Breast Cancer Treatments Are Rapidly Expanding
EP: 9.Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma
EP: 10.Pharmacy Focus: Oncology Edition - A Look Into Psychedelic Medicines for Oncology Care
EP: 11.Pharmacy Focus: Oncology Edition - PARP Inhibitors Are Changing the Game in Prostate Cancer
EP: 12.Pharmacy Focus: Oncology Edition- A Practical, Real-World Understanding of the Enhancing Oncology Model
Related Videos
Related Content
